12H group (n = 19) | 24H group (n = 20) | p value | |
---|---|---|---|
Age, month | 25 [2–75] | 32 [7–118] | 0.196 |
Men | 11 (57.9) | 11 (55.0) | 1.00 |
Days of illness at enrollment | 5 [4–7] | 5 [4–6] | 0.915 |
Risk score | 4 [0–7] | 1 [0–6] | 0.022 |
Laboratory data | |||
White blood cell count, 109/L | 12.4 ± 3.4 | 12.4 ± 4.0 | 0.993 |
Neutrophils, % | 71.2 ± 13.3 | 67.2 ± 15.6 | 0.403 |
Platelet count, 1010/L | 31.1 ± 7.3 | 36.2 ± 9.3 | 0.067 |
Albumin, g/L | 3.3 ± 0.4 | 3.5 ± 0.4 | 0.111 |
Creatinine, mg/dL | 0.27 ± 0.06 | 0.27 ± 0.07 | 0.664 |
Aspartate aminotransferase, U/L | 99 ± 159 | 38 ± 21 | 0.092 |
Sodium, mEq/L | 133 ± 3 | 137 ± 3 | < 0.01 |
C-reactive protein, mg/dL | 7.3 ± 3.9 | 6.4 ± 5.9 | 0.564 |
IgG, mg/dL | 624 ± 155 | 754 ± 167 | 0.021 |